Suzhou MedicalSystem Technology Future Growth

Future criteria checks 5/6

Suzhou MedicalSystem Technology is forecast to grow earnings and revenue by 134.1% and 91.1% per annum respectively while EPS is expected to grow by 133.6% per annum.

Key information

134.1%

Earnings growth rate

133.6%

EPS growth rate

Healthcare Services earnings growth	29.3%
Revenue growth rate	91.1%
Future return on equity	n/a
Analyst coverage	Low
Last updated	01 Dec 2023

Recent future growth updates

No updates

Recent updates

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Shares Leap 30% Yet They're Still Not Telling The Full Story

Mar 08

Earnings and Revenue Growth Forecasts

SHSE:603990 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	6,724	527	N/A	-26	1
12/31/2024	3,906	201	N/A	-466	1
3/31/2024	659	-249	-810	-349	N/A
12/31/2023	618	-269	-916	-317	N/A
9/30/2023	450	-76	-857	-275	N/A
6/30/2023	316	-44	-624	-63	N/A
3/31/2023	319	13	-151	65	N/A
12/31/2022	306	34	26	51	N/A
9/30/2022	342	45	16	55	N/A
6/30/2022	345	46	-8	27	N/A
3/31/2022	364	45	-22	17	N/A
12/31/2021	354	42	-5	36	N/A
9/30/2021	357	48	64	93	N/A
6/30/2021	370	60	76	102	N/A
3/31/2021	339	59	96	106	N/A
12/31/2020	308	35	92	100	N/A
9/30/2020	325	38	51	55	N/A
6/30/2020	302	33	50	56	N/A
3/31/2020	309	35	45	50	N/A
12/31/2019	333	47	9	22	N/A
9/30/2019	302	55	2	16	N/A
6/30/2019	304	50	30	43	N/A
3/31/2019	289	56	19	37	N/A
12/31/2018	284	55	32	49	N/A
9/30/2018	263	33	15	44	N/A
6/30/2018	265	49	-27	15	N/A
3/31/2018	272	49	-51	-8	N/A
12/31/2017	269	51	N/A	-6	N/A
9/30/2017	262	53	N/A	7	N/A
6/30/2017	254	49	N/A	7	N/A
3/31/2017	245	44	N/A	32	N/A
12/31/2016	241	45	N/A	33	N/A
9/30/2016	235	56	N/A	N/A	N/A
12/31/2015	202	39	N/A	38	N/A
12/31/2014	180	39	N/A	41	N/A
12/31/2013	143	31	N/A	33	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603990 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).

Earnings vs Market: 603990 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 603990 is expected to become profitable in the next 3 years.

Revenue vs Market: 603990's revenue (91.1% per year) is forecast to grow faster than the CN market (14.7% per year).

High Growth Revenue: 603990's revenue (91.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 603990's Return on Equity is forecast to be high in 3 years time

Suzhou MedicalSystem Technology Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Recent updates

First quarter 2024 earnings released: EPS: CN¥0.03 (vs CN¥0.038 loss in 1Q 2023)

Suzhou MedicalSystem Technology Co., Ltd., Annual General Meeting, May 20, 2024

Suzhou MedicalSystem Technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Shares Leap 30% Yet They're Still Not Telling The Full Story

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) announces an Equity Buyback for CNY 30 million worth of its shares.

Suzhou MedicalSystem Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: CN¥0.075 loss per share (vs CN¥0.008 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.26 loss per share (vs CN¥0.041 profit in 2Q 2022)

Suzhou MedicalSystem Technology Co., Ltd. to Report First Half, 2023 Results on Aug 18, 2023

First quarter 2023 earnings released: CN¥0.05 loss per share (vs CN¥0.046 profit in 1Q 2022)

Third quarter 2022 earnings released: CN¥0.011 loss per share (vs CN¥0.012 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.054 (vs CN¥0.046 in 2Q 2021)

Investor sentiment deteriorated over the past week

Mianyang Haoxiang Holdings Co., Ltd agreed to acquire an unknown minority stake in Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million.

Suzhou MedicalSystem Technology Co., Ltd. announced that it expects to receive CNY 238.92928 million in funding from Mianyang Haoxiang Holdings Co., Ltd

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Now 24% undervalued

Now 22% undervalued

Now 21% undervalued

Second quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.06 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.12 loss in 1Q 2020)

New 90-day low: CN¥29.95

New 90-day low: CN¥30.70

New 90-day low: CN¥31.00

New 90-day low: CN¥37.65

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) signed an agreement to acquire remaining 49% stake in Haikou Mary Hospital Co., Ltd.

Third quarter earnings released

Suzhou MedicalSystem Technology Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

New 90-day low: CN¥41.30

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) signed an equity acquisition intention agreement to acquire 51% stake in Heilongjiang Tianyuan Obstetrics and Gynecology Hospital Co., Ltd. from Tibet Daming Investment Management Co., Ltd. and Xue Weiwei for approximately CNY 170 million.

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) signed a letter of intent to acquire 51% stake in a Hospital located in Heilongjiang for approximately CNY 170 million.

Earnings released

Zhongruo (Suzhou) Asset Management Co., Ltd. completed the acquisition of 5.34% stake in Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) from Hangzhou Anshi Investment Management Partnership Enterprise (Limited Partnership).

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies